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Objective:  To  estimate  the  excess  deaths  attributed  to  inﬂuenza  in  Spain,  using  age-speciﬁc  generalized
linear  models  (GLM)  and  the  Serﬂing  model  for the  period  1999-2005.
Method:  We  reviewed  mortality  from  inﬂuenza  and  pneumonia  and  all-cause  deaths.  We  used  an  addi-
tive GLM  procedure,  including  the  numbers  of weekly  deaths  as  a  response  variable  and  the  number
of  inﬂuenza  virus  and  respiratory  syncytial  virus  weekly  isolates,  the population  and  two  variables  to
adjust  for  annual  ﬂuctuations  as  covariates.  Using  the  Serﬂing  model,  we  removed  the  trend  and  applied
a  temporal  regression  model,  excluding  data  from  December  to  April  to account  for the expected  baseline
mortality  in  the  absence  of inﬂuenza  activity.
Results: Globally,  the  excess  mortality  attributable  to  inﬂuenza  was  1.1  deaths  per 100,000  for inﬂuenza
and  pneumonia  and  11 all-cause  deaths  per 100,000  using  the  GLM  model.  The highest  mortality  rates
were  obtained  with  the  Serﬂing  model  in  adults  older  than  64 years,  with  an  excess  mortality  attributable
to  inﬂuenza  of  57  and  164  deaths  per 100,000  for  inﬂuenza  and  pneumonia  and  all-cause,  respectively.
Conclusions:  The  GLM  model,  which  takes  viral  activity  into  account,  yields  systematically  lower  estimates
of excess  mortality  than  the  Serﬂing  model.  The  GLM  model  provides  independent  estimates  associated
with  the  activity  of  different  viruses  and  even  with  other  factors,  which  is  a signiﬁcant  advantage  when
trying  to understand  the  impact  of  viral  respiratory  infections  on  mortality  in  the  Spanish  population.
©  2011  SESPAS.  Published  by  Elsevier  España,  S.L.  All rights  reserved.
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Objetivo:  Estimar  los  excesos  de  mortalidad  atribuible  a la  gripe  en  Espan˜a  por  grupos  de  edad,  usando
modelos  lineales  generalizados  (MLG)  y modelos  Serﬂing,  para  el  periodo  1999-2005.
Método:  Se  revisó  la mortalidad  por  gripe  y  neumonía  y por  todas  las  causas.  En  el MLG  aditivo  se incluyó
como  variable  respuesta  el  número  de  defunciones  semanales,  y  como  covariables  el número  de  ais-
lamientos  semanales  de  virus  de  la  gripe  y de  virus  respiratorio  sincitial,  la población  y dos variables  que
corrigen  las ﬂuctuaciones  anuales.  En  el modelo  Serﬂing  se  eliminó  previamente  la  tendencia  y se  aplicó
un  modelo  de  regresión  cíclica,  excluyendo  los  valores  desde  diciembre  hasta  abril,  para  cuantiﬁcar  la
mortalidad  esperada  en ausencia  de  actividad  gripal.
Resultados:  El  exceso  de mortalidad  atribuible  a la  gripe  fue  de  1,1 defunciones  por  100.000  habitantes  por
gripe y neumonía,  y de  11  defunciones  por  todas  las  causas  usando  el  MLG.  Las  tasas  de  mortalidad  más
altas se observaron  con  el  modelo  Serﬂing  en  los  mayores  de  64  an˜os,  con un  exceso  de  mortalidad  de  57
y 164  defunciones  por  100.000  habitantes  por  gripe  y neumonía  y  por  todas  las  causas,  respectivamente.
Conclusiones:  El  MLG  tiene  en cuenta  la  actividad  viral  y  produce  de forma  sistemática  estimaciones
de  exceso  de mortalidad  más  bajas  que  el modelo  Serﬂing.  El  MLG  tiene  la  ventaja  de dar  estima-
ciones  independientes  asociadas  a la  actividad  de  diferentes  virus  y otros  factores,  lo cual  representa
un paso  importante  cuando  intentamos  entender  el  impacto  de  las  infecciones  virales  respiratorias  en  la
blaci
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The number of inﬂuenza-attributable deaths is difﬁcult to
stimate directly as inﬂuenza infection is not usually laboratory-
onﬁrmed, and a diagnosis of inﬂuenza rarely appears as the
ain cause of death in death certiﬁcates. Additionally, many
∗ Corresponding author.
E-mail address: teresalc@isciii.es (T. López-Cuadrado).
213-9111/$ – see front matter © 2011 SESPAS. Published by Elsevier España, S.L. All righ
oi:10.1016/j.gaceta.2011.09.033ón.
ESPAS.  Publicado  por  Elsevier  España,  S.L.  Todos  los  derechos  reservados.
inﬂuenza-related deaths occur in patients with underlying condi-
tions in which signs of inﬂuenza infection are already difﬁcult to
detect, and the reason for decompensation of the patient’s primary
illness has been laid-aside.1
Consequently, inﬂuenza-related mortality should be quanti-
ﬁed indirectly, using models estimating the observed excess
deaths in winter seasons above the predicted mortality baseline
in the absence of inﬂuenza virus circulation.2,3 For many years,
the term “inﬂuenza-related mortality” or “inﬂuenza-associated
mortality”4–7 has been widely used in the scientiﬁc literature to
ts reserved.
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eport ﬁgures which reﬂect the impact of inﬂuenza on popula-
ion mortality. These estimates were normally used to establish
he cost-effectiveness and cost-beneﬁt of the various strategies
vailable for the prevention and control of this disease.8,9 These
alculations used different sources of data or for cause of death,
s well as distinct statistical models. Thus, different authors fre-
uently reported excess pneumonia and inﬂuenza deaths,10–12
xcess deaths from respiratory and circulatory diseases10,13 or total
xcess deaths,10–12 depending on the cause of death taken as ref-
rence. Similarly, distinct statistical models were used, which did
ot always include measures of inﬂuenza activity.
Among the ﬁrst models used and never abandoned despite
riticism of the methodology,14 was that proposed by Serﬂing4
n 1963, a classical approach based on a cyclic regression model,
hich continued to be used by different authors with slight
odiﬁcations depending on their needs.3,12 When an alternative
o these models and reliable information about inﬂuenza activity
ecame available, Poisson regression models (or generalized linear
odels based on Poisson distribution function) started to be used,
ncluding not only data on inﬂuenza activity but also data on other
espiratory viruses (respiratory syncytial virus) as covariables,
hich could explain inﬂuenza-attributable excess deaths.
These methods for indirect estimation of excess mortality have
een used in several studies. In the United States, an excess
ortality rate of 19.6 per 100,000 inhabitants was found, using
ll-cause deaths11 as outcome, and 2.4 per 100,000 inhabitants
sing inﬂuenza and pneumonia as causes of death.13,15 In Europe,
nﬂuenza-associated mortality using all-cause deaths as outcome
anged from an excess mortality rate of 13 per 100,000 inhabi-
ants in Portugal16 to 26 per 100,000 in the Czech Republic.17 With
nﬂuenza and pneumonia as outcome, reported excess mortality
ates associated with inﬂuenza were between 1.45 per 100,000 in
ortugal16 and 3 per 100,000 in Italy.12 In Spain, all-cause excess
ortality attributable to inﬂuenza epidemics was  estimated in
atalonia as 34.4 weekly deaths among persons aged over 64
ears18 (190.79 per 100,000 inhabitants annually).
The aim of this study was to estimate the mortality attributable
o inﬂuenza in persons over 44 years old during the inﬂuenza sea-
ons from 1999-2000 to 2004-2005 in Spain. We  also aimed to
ssess the two different models, with and without measures of
nﬂuenza activity, to better understand the strengths and weak-
esses of the two methods in order to evaluate the burden of
nﬂuenza disease.
ethods
We analyzed the national mortality data for the period 1999-
005 provided by the National Statistics Institute, specifying the
ain cause of death codiﬁed according to the 10th International
lassiﬁcation of Diseases (ICD-10). All-cause deaths and the codes
f death related to inﬂuenza and pneumonia (J09-J18) were taken
nto account.
Viral activity data (including inﬂuenza and respiratory syn-
ytial viruses only) were obtained from the Spanish Inﬂuenza
urveillance System (SISS) and the Microbiological Information
ystem (MIS), respectively. The SISS is a sentinel system that aims
o provide timely epidemiological and virological information on
nﬂuenza activity in Spain. The system covers 2% of the total pop-
lation of the 17 (out of 19) participating Spanish regions. The MIS
s a national centralized system in which test results for all infec-
ious diseases, including respiratory syncytial virus are collected,
overing 25% of the Spanish population.19 Both viral data corre-
ponded to week 40 of a particular year to week 20 of the following
ear.nit. 2012;26(4):325–329
The population data used (annual estimates during the study
period) was also provided by the National Statistics Institute.
The presence of the date of death in the examined mortality
records allowed deaths to be distributed by epidemiological week
during the period analyzed. The viral activity data were also
obtained with the same periodicity. The results obtained were
displayed by season (from week 40 of a particular year to week
20 of the following year) to take the seasonal pattern of inﬂuenza
activity into account.
Two types of models were used to estimate the number of
inﬂuenza-attributable deaths. The ﬁrst model, the Serﬂing regres-
sion model adapted by Simonsen et al,3,7 did not include viral
activity measures. This model, which assumes that errors are dis-
tributed according to a normal distribution function, consisted
of applying a cyclic regression to the series of weekly mortal-
ity rates observed, previously removing the trend. To quantify
the expected baseline mortality in the absence of inﬂuenza activ-
ity, we ran the model, excluding the weekly values between
December and April of each year. The weekly excess mortal-
ity was  calculated as the difference between observed mortality
rates and expected mortality rates. The model used was the
following:
Y(ti) =  ˛ + ˇ1 cos(
2ti
52
)  + ˇ2 sin(
2ti
52
)  + ˇ3ti + ˇ4t2i + error(ti)
where Y(ti) is the number of deaths for week ti, two  variables to
adjust seasonal ﬂuctuations (sine and cosine) and the linear and
squared terms in ti.
The second model took measures of viral activity into account.
This model was an additive generalized linear model (GLM), which
assumes that errors are distributed according to a Poisson dis-
tribution function. Its equation included the number of weekly
deaths due to the above-mentioned causes as the dependent vari-
able Y(ti), and, as covariables, two  variables to adjust seasonal
ﬂuctuations (sine and cosine), the linear and squared terms in ti,
the number of inﬂuenza (A and B types) and respiratory syncy-
tial virus (RSV) isolates per week, and  as a population offset
variable:
Y(ti) =  ˛ exp{ˇ0 + ˇ1 cos(
2ti
52
)  + ˇ2 sin(
2ti
52
) + ˇ3ti
+ ˇ4t2i + ˇ5A(ti) + ˇ6B(ti) + ˇ7RSV(ti) + +error(ti)}
Excess inﬂuenza-attributable deaths were calculated by tak-
ing into account the difference between the excess predicted by
the model and that obtained when assuming 0 as the number of
inﬂuenza virus isolates.20 The excess was presented as the absolute
number of deaths and mortality rates/100,000 inhabitants.
All of the analyses were done with the statistics program Stata,
version 11.
Results
Estimates of global excess inﬂuenza-attributable mortality in
Spain, from inﬂuenza seasons 1999-2000 to 2004-2005, using the
GLM and Serﬂing models are shown in table 1. The highest mortal-
ity rates were observed during the 2004-2005 season (ﬁgs. 1 and 2),
with an estimated excess mortality rate due to inﬂuenza and pneu-
monia and all-cause deaths of 2.64 and 23.15 deaths per 100,000
inhabitants, respectively using the GLM model, and of 6.55 and
74.00, respectively, using the Serﬂing model. Conversely, with both
models, the lowest excess mortality was found during the 2000-
2001 inﬂuenza season (table 1).
Table 2 shows inﬂuenza and pneumonia, and all-cause excess
mortality during the study period for the groups aged 45-64 years
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Table  1
Inﬂuenza and pneumonia and all-cause excess mortality obtained with the generalized linear model and Serﬂing model in Spain, 1999-2005.
Inﬂuenza seasons Inﬂuenza and pneumonia All-cause
GLM Serﬂing GLM Serﬂing
Excess Rate /100,000 Excess Rate /100,000 Excess Rate /100,000 Excess Rate /100,000
1999-2000 262 0.65 1,836 4.51 2,932 7.00 18,205 44.73
2000-2001 11 0.01 28 0.06 181 0.45 0 0.00
2001-2002 693 1.69 1,250 3.02 7,266 17.72 14,696 35.57
2002-2003 99 0.24 116 0.28 1,192 2.88 3,020 7.19
2003-2004 490 1.17 673 1.58 5,865 13.96 8,421 19.75
2004-2005 1,127 2.64 2,833 6.55 9,871 23.15 31,979 74.00
Total  2,682 1.08 6,736 2.68 27,307 10.97 76,321 30.42
GLM: generalized linear model.
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Table 2
Inﬂuenza and pneumonia and all-cause excess mortality by age group in Spain,
1999-2005.
GLM Serﬂing
Excess Rate/100,000 Excess Rate/100,000
45-64 years old
Inﬂuenza and pneumonia 103 0.18 186 0.33
All-cause 1,301 2.31 2,131 3.77
>64  years old
Inﬂuenza and pneumonia 2,473 6.00 6,413 15.25igure 1. Inﬂuenza and pneumonia mortality rates and mortality baseline for all
ear groups with the Sterling model: seasons 1998-1999 to 2004-2005 (Spain).
nd 64 or more years, obtained with both models. The highest mor-
ality rates were observed for the group aged 64 years or more,
ccounting for 6 and 57 deaths per 100,000 inhabitants, attributable
o inﬂuenza and pneumonia and all-cause, respectively. Values
etween 2.5 and 2.8 times higher were obtained with the Serﬂing
odel.
We estimated an annual overall average of 1,122 inﬂuenza-
ttributable deaths (range: 28 in 2000-2001 to 2,833 in 2004-2005)
uring the study period using the inﬂuenza and pneumonia out-
ome with the Serﬂing model, and 447 inﬂuenza-attributable
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igure 2. Inﬂuenza and pneumonia and all-cause excess mortality for all year
roups with the GLM model. Seasons 1999-2000 to 2004-2005 (Spain).All-cause 23,560 57.05 68,997 164.10
GLM: generalized linear model.
deaths (range: 11 in 2000-2001 to 1,127 in 2004-2005) with the
GLM model.
Discussion
The use of two different models to estimate inﬂuenza-
attributable mortality during a speciﬁed period has been fostered
by the need to compare the results obtained according to whether
viral activity is taken into account or not. Excess inﬂuenza-
attributable mortality patterns in the different seasons and age
groups analyzed were similar with the GLM and Serﬂing mod-
els. However, the GLM model, which takes viral activity into
account, yields systematically lower excess mortality estimates
than the Serﬂing model, whose results have already been rated as
conservative12,20 as the estimation is based on shorter time periods.
When a model such as the GLM is used, one of the assumptions is
that the number of deaths due to a speciﬁc virus in any given week is
directly proportional to the number of virus detections in that week,
independently of the period of the year considered. Additionally,
when using an additive model (identity link) the total number of
deaths would be the sum of contributions from each virus plus the
number of deaths due to other causes.21 For this reason, although
the GLM uses a longer time period to estimate the excess than the
Serﬂing model, the higher speciﬁcity due to inclusion of viral activ-
ity could lead to lower estimates of excess inﬂuenza-attributable
deaths.
The way  in which the viral activity measures are incorporated
into the model could also lead to differences. We worked with
absolute frequencies of specimens testing positive to the differ-
ent viruses for which information was available, while some other
authors have preferred to consider isolate rates of the different
viruses to carry out similar estimates in their own  countries.11,22
These authors justiﬁed this use by the differences in coverage level
and performance of the surveillance systems, factors which can be
of particular importance when the period analyzed is long. Working
with isolate rates implies knowing how many samples were ana-
lyzed, which is not always possible, and does not always guarantee
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etter prediction.23 Nevertheless, working with absolute frequen-
ies of isolates as a measure of the viral activity of different viruses
ould not have introduced an important bias, because of the good
erformance of our surveillance system and its constant coverage
n the period analyzed.24
Differences in estimates obtained with the two  models could
lso be attributed to the periodicity of the data analyzed (weekly
ata in our case) and, for the GLM model, could also be due the
dditive function used in the Poisson distribution. There is some
ontroversy25,26 about the correct use of logarithmical models (log
ink) to estimate excess deaths, as in these models the number of
eaths increases exponentially with the number of isolates, and
he effects of each virus on the number of deaths are a multiplica-
ive function, something which is not really permissible. Whether
his assumption is accepted or not, what is notable is that additive
odels such as ours give lower estimates of excess deaths.
We  obtained an excess mortality rate due to pneumonia and
nﬂuenza of 15.3 deaths/100,000 inhabitants in persons aged over
4 years, in reasonable agreement with other countries using the
erﬂing model12,26 or Poisson model.27 Using the GLM model, we
btained lower estimates of inﬂuenza-associated mortality in
he same age group than those reported in other studies from
he southern hemisphere.28
In both models we used all-cause mortality and “inﬂuenza and
neumonia” as more speciﬁc causes of inﬂuenza-associated deaths.
 more speciﬁc indicator such as excess deaths due to inﬂuenza and
neumonia would be desirable to assess the impact of seasonal
nﬂuenza epidemics more accurately,18 but would also have some
rawbacks. Since not all inﬂuenza-associated deaths are coded
s “inﬂuenza and pneumonia”, the impact of inﬂuenza could be
nderestimated with this indicator.29 In addition, mortality from
ll causes likely leads to an overestimation of inﬂuenza-related
eaths. Between the 1999-2000 and 2004-2005 inﬂuenza sea-
ons, we estimated an average annual excess of 2,682 and 27,307
nﬂuenza-related deaths using inﬂuenza and pneumonia or all-
ause deaths, respectively. The real impact of seasonal inﬂuenza
n mortality would be within this range and varies with the
eason and the predominant inﬂuenza virus circulating in each
eason.
To assess the differences between the magnitude of the two
odels and to exclude the possibility of residual confounding by
easonality or other factors that could affect our estimates of excess
nﬂuenza-associated deaths, we carried out an analysis using all
eaths from accidents, according to the ICD-10 (V00-Y89), as a
ontrol group in the period 1999-2005 (data not shown). The GLM
odel estimated less than 1% of excess deaths from accidents in all-
ge groups attributed to inﬂuenza, while in the Serﬂing model this
ercentage was 4%. These errors might be explained by the clear
easonality of car accidents or by bias introduced by the model in
he calculation of excess deaths. These ﬁndings suggest that the
LM model might estimate excess deaths attributed to inﬂuenza
ore accurately than the Serﬂing model.
Despite the differences in mortality estimates obtained with
he models used, both models showed the highest inﬂuenza-
ttributable mortality rates for the 2004-2005 season, when the
ISS recorded the highest inﬂuenza incidence rates since the 1996-
997 seasonal inﬂuenza period.30 Likewise, in the 2000-2001
eason, which showed the lowest inﬂuenza-attributable excess
ortality rates with both models, inﬂuenza activity did not rise
bove the baseline threshold for the whole of Europe.30 Inﬂuenza-
ssociated mortality can be described by considering the circulating
irus strain with both models. As previously reported,13 during sea-
ons with predominant circulation of inﬂuenza A(H3N2) viruses
2001-2002, 2003-2004, 2004-2005),30 the average annual excess
eaths was higher than in seasons when A(H3N2) was not predom-
nant (1999-2000, 2000-2001, 2002-2003).30nit. 2012;26(4):325–329
Irrespective of the different results obtained with the two mod-
els, which could be important depending on the use made of these
results, the GLM model, despite its greater complexity, has the
advantage of giving independent estimates associated with the
activity of different viruses and even with other measurable factors,
which represents an important step when trying to understand the
impact of viral respiratory infections on mortality in our population.
What is known on the topic?
The impact of seasonal inﬂuenza is usually quantiﬁed indi-
rectly, using models estimating the observed excess deaths in
winter seasons above the predicted mortality baseline in the
absence of inﬂuenza virus circulation. Estimates of inﬂuenza-
associated deaths in Spain are scarce. This study provides
estimates of the mortality attributable to inﬂuenza in the
inﬂuenza seasons from 1999-2000 to 2004-2005 in Spain, using
two models: one which includes measures of inﬂuenza viral
activity and another that does not.
What does this study contribute to the literature?
The annual overall average for inﬂuenza-attributable deaths
during the inﬂuenza seasons from 1999-2000 to 2004-2005 in
Spain, ranged from 447 to 1,122 for inﬂuenza and pneumonia
causes of death, depending on the method used. This study
represents a major improvement in assessing the burden of
inﬂuenza disease in Spain and provides useful evidence to
guide policies for inﬂuenza prevention and control.
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